Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuto Yagi

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 14, 2026
Prognostic Impact and Metastasis Propensity of Grade Group 5 Prostate Cancer Following Permanent Seed Implantation Brachytherapy-Based Trimodality Therapy: Implications for Intensified Staging and Systemic Therapy OptimizationTomomasa Matsuo, Yu Ozawa, Atsunori Yorozu, et al.
Brachytherapy|August 16, 2014
Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan: outcomes of 1300 patientsAtsunori Yorozu, Nobuko Kuroiwa, Akane Takahashi, et al.
Brachytherapy|March 1, 2016
Predictive factors for urinary toxicity after iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapyTakahisa Eriguchi, Atsunori Yorozu, Nobuko Kuroiwa, et al.
Urology Case Reports|June 24, 2016
The Initial Case Report: Salvage Robotic Assisted Radical Prostatectomy After Heavy Ion RadiotherapyChoichiro Ozu, Keisuke Aoki, Ken Nakamura, et al.
Human Genome Variation|January 17, 2022
A novel pathogenic variant of the FH gene in a family with hereditary leiomyomatosis and renal cell carcinomaYasuto Yagi, Naoko Abeto, Junichi Shiraishi, et al.
International Journal of Clinical Oncology|October 31, 2013
Five-year potency preservation after iodine-125 prostate brachytherapyShuichi Nishimura, Atsunori Yorozu, Toshio Ohashi, et al.
Brachytherapy|June 25, 2018
Predictive factors of long-term rectal toxicity following permanent iodine-125 prostate brachytherapy with or without supplemental external beam radiation therapy in 2216 patientsTomoki Tanaka, Atsunori Yorozu, Shinya Sutani, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 14, 2026
Prognostic Impact and Metastasis Propensity of Grade Group 5 Prostate Cancer Following Permanent Seed Implantation Brachytherapy-Based Trimodality Therapy: Implications for Intensified Staging and Systemic Therapy OptimizationTomomasa Matsuo, Yu Ozawa, Atsunori Yorozu, et al.
Brachytherapy|August 16, 2014
Permanent prostate brachytherapy with or without supplemental external beam radiotherapy as practiced in Japan: outcomes of 1300 patientsAtsunori Yorozu, Nobuko Kuroiwa, Akane Takahashi, et al.
Brachytherapy|March 1, 2016
Predictive factors for urinary toxicity after iodine-125 prostate brachytherapy with or without supplemental external beam radiotherapyTakahisa Eriguchi, Atsunori Yorozu, Nobuko Kuroiwa, et al.
Urology Case Reports|June 24, 2016
The Initial Case Report: Salvage Robotic Assisted Radical Prostatectomy After Heavy Ion RadiotherapyChoichiro Ozu, Keisuke Aoki, Ken Nakamura, et al.
Human Genome Variation|January 17, 2022
A novel pathogenic variant of the FH gene in a family with hereditary leiomyomatosis and renal cell carcinomaYasuto Yagi, Naoko Abeto, Junichi Shiraishi, et al.
International Journal of Clinical Oncology|October 31, 2013
Five-year potency preservation after iodine-125 prostate brachytherapyShuichi Nishimura, Atsunori Yorozu, Toshio Ohashi, et al.
Brachytherapy|June 25, 2018
Predictive factors of long-term rectal toxicity following permanent iodine-125 prostate brachytherapy with or without supplemental external beam radiation therapy in 2216 patientsTomoki Tanaka, Atsunori Yorozu, Shinya Sutani, et al.
Pageof 2